Condensed Consolidated Statements Of Operations (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Revenues:
Net product sales	$ 264,123	$ 220,789
Other product related revenues	7,349	12,163
Total revenues	271,472	232,952
Cost of goods sold, excluding amortization expense	164,804	120,539
Amortization expense	8,822	2,761
Total cost of goods sold	173,626	123,300
Gross margin	97,846	109,652
Operating expenses:
Research and development	29,900	10,710
Selling, general and administrative	42,159	46,945
Intangible asset impairment	2,000
Settlements and loss contingencies, net	45,000	190,560
Total operating expenses	119,059	248,215
Operating loss	(21,213)	(138,563)
Interest income	136	423
Interest expense	(3,094)	(150)
Loss from continuing operations before provision (benefit) for income taxes	(24,171)	(138,290)
Provision (benefit) for income taxes	4,525	(29,446)
Loss from continuing operations	(28,696)	(108,844)
Discontinued operations:
Provision for income taxes	27	127
Loss from discontinued operations	(27)	(127)
Net loss	$ (28,723)	$ (108,971)
Basic loss per share of common stock:
Loss from continuing operations	$ (0.79)	$ (3.07)
Loss from discontinued operations	$ 0.00	$ 0.00
Net loss	$ (0.79)	$ (3.07)
Diluted loss per share of common stock:
Loss from continuing operations	$ (0.79)	$ (3.07)
Loss from discontinued operations	$ 0.00	$ 0.00
Net loss	$ (0.79)	$ (3.07)
Weighted average number of common shares outstanding:
Basic	36,305	35,500
Diluted	36,305	35,500